Belnacasan

CAT: 0804-HY-13205-01Size: 5 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-13205-01Size:5 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Belnacasan (VX-765) is an orally bioactive proagent of VRT-043198, which is a potent and selective inhibitor of IL-converting enzyme (ICE) /caspase-1 with Kis of 0.8 nM and less than 0.6 nM for caspase-1 and caspase-4, respectively. Belnacasan (VX-765) inhibits the release of LPS-induced IL-1β and IL-18 by human PBMCs with an IC50 of ~0.7 μM[1][2].

CAS Number

273404-37-8

Product Name Alternative

VX-765

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Caspase

Type

Reference compound

Related Pathways

Apoptosis

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/VX-765.html

Purity

99.99

Solubility

DMSO : 100 mg/mL (ultrasonic) |H2O : 1 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

ClC1=C(N)C=CC(C(N[C@@H](C(C)(C)C)C(N2[C@H](C(N[C@H]3CC(O[C@H]3OCC)=O)=O)CCC2)=O)=O)=C1

Molecular Formula

C24H33ClN4O6

Molecular Weight

509.00

Precautions

H302, H315, H319, H335

References & Citations

[1]Stack JH, et al. IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients. J Immunol. 2005 Aug 15;175 (4) :2630-4.|[2]Wannamaker W, et al. (S) -1- ((S) -2-{[1- (4-amino-3-chloro-phenyl) -methanoyl]-amino}-3,3-dimethyl-butanoyl) -pyrrolidine-2-carboxylic acid ((2R,3S) -2-ethoxy-5-oxo-tetrahydro-furan-3-yl) -amide (VX-765), an orally available selective interleukin (IL) -converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18. J Pharmacol Exp Ther. 2007 May;321 (2) :509-16.|[3]Ravizza T, et al. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia. 2006 Jul;47 (7) :1160-8.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C, 3 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Isoform

Caspase 1

Alternative Products

Catalog	Name
BUP15367-01	Belnacasan
MBS386389-01	VX-765 (Belnacasan)
203165	Belnacasan (VX765)
C08374-1g	Belnacasan (VX-765)
A10984-200	VX-765 (Belnacasan) 200mg
TBI4399-5MG	Belnacasan, Caspase 1 (ICE) inhibitor
A10984-25	VX-765 (Belnacasan) 25mg
A10984-2	VX-765 (Belnacasan) 2mg

Belnacasan

Alternative Products

Popular Products